P Valent

Metal ion-induced toxic histamine release from human basophils and mast cells.

R Slavicek, A Ellinger, W Sperr, 1998, Journal of biomedical materials research.

Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells

G. Superti-Furga, K. Bennett, O. Hantschel, 2009, Leukemia.

Characterization of human prostate mast cells and their increase in periprostatic vein thrombosis.

P. Valent, K. Lechner, P. Samorapoompichit, 2001, American journal of clinical pathology.

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.

W. Scheithauer, P. Valent, P. Angelberger, 1994, The New England journal of medicine.

Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy.

P Hübsch, M Peck-Radosavljevic, P. Valent, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders

T. George, K. Sotlar, A. Reiter, 2017, Leukemia.

A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells

G. Superti-Furga, K. Bennett, O. Hantschel, 2010, Leukemia.

Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.

P Valent, W H Hörl, J Streicher, 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

A Orfao, A. Órfão, U. Johansson, 2014, Leukemia.